低至中亲和力Fcγ受体基因变异与临床血小板输注无效的关联及功能相关性
该回顾性病例对照研究纳入2005至2013年间因严重血小板输注无效送检同种免疫检测的患者,比较检出抗血小板抗体者(n=181)与民族匹配的健康对照(n=180)之间Fcγ受体已知功能性拷贝数变异和单核苷酸多态性的差异。结果显示,所检测的Fcγ受体基因变异似乎均与严重血小板输注无效的发生无关,与免疫性血小板减少症中的观察相反,不支持通过检测Fcγ受体遗传背景来识别血小板输注无效高危患者。
要点
- 所检测的Fcγ受体基因变异似乎均与严重血小板输注无效的发生无关。
- 与免疫性血小板减少症的观察相反,Fcγ受体基因变异似乎不影响血小板输注无效的发生风险。
- 结果不支持通过检测Fcγ受体遗传背景来识别血小板输注无效高危患者。
核心结论
- 所检测的Fcγ受体基因变异似乎均与严重血小板输注无效的发生无关。
- 与免疫性血小板减少症中的观察相反,Fcγ受体基因变异似乎不影响发生血小板输注无效的机会。
- 结果不支持通过检测Fcγ受体遗传背景来识别血小板输注无效高危患者。
研究设计与样本
- 回顾性纳入2005至2013年间因严重血小板输注无效而送检同种免疫诊断检测的患者。
- 采用病例对照研究,比较检出抗血小板抗体者(n=181)与民族匹配的健康对照(n=180)。
主要发现
- 所检测的Fcγ受体已知功能性拷贝数变异和单核苷酸多态性似乎均与严重血小板输注无效的发生无关。
临床怎么用
- 原文结论未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Inadequate responses to platelet transfusions (i.e., platelet transfusion refractoriness [PLT refractoriness]) are a serious problem. Multiple factors contribute to low yields upon platelet transfusion, among which are platelet-reactive allo-antibodies. Platelet-reactive allo-antibodies occur in up to 30% of patients receiving multiple transfusions, and presumably lead to rapid destruction of the transfused platelets via receptors for IgG, the Fc-gamma receptors (FcγRs). Genetic variation in FcγRs is associated with susceptibility to immune thrombocytopenia, in which autoantibodies against platelets cause thrombocytopenia. OBJECTIVES: We hypothesized that genetic variation in FcγRs may also influence PLT refractoriness in allo-immunized patients and could help in identifying the patients at risk. PATIENTS/METHODS: Patients with severe PLT refractoriness for whom diagnostic testing for allo-immunization was requested in the period of 2005 to 2013 were retrospectively included. A case-control study was performed comparing patients in whom platelet-reactive antibodies were detected (n = 181) with ethnically matched healthy controls (n = 180) to determine differences in all known functional copy number variations and single nucleotide polymorphisms in FcγRs. RESULTS AND CONCLUSIONS: None of the tested FcγR genetic variations seemed associated with the development of severe PLT refractoriness. In contrast to observations in immune thrombocytopenia, genetic variation in FcγRs does not seem to influence the chance to develop PLT refractoriness. Our results do not support determination of FcγR genetic background as a means to identify patients most at risk for PLT refractoriness.
引用
- Nagelkerke SQ, Porcelijn L, Geissler J, et al. The association and functional relevance of genetic variation in low-to-medium-affinity Fc-gamma receptors with clinical platelet transfusion refractoriness. J Thromb Haemost. 2020. PMID: 32588549. doi:10.1111/jth.14892
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。